contact: webmaster

Center for Experimental Therapeutics
and Reperfusion Injury


Harvard Medical School - Department of
Anesthesiology, Perioperative and Pain Medicine

75 Francis Street, Boston, MA 02115
(617) 278-0690

Professor Charles N. Serhan
The Simon Gelman Professor of Anesthesia, Perioperative and Pain Medicine
(Biochemistry and Molecular Pharmacology),
Harvard Medical School and
BWH Endowed Distinguished Scientist



Seminars Journals



Center Faculty - 2005

Charles N. Serhan
Principal Investigator

Laboratory Website
Publications
   Previous Publications
Program Project P50-DE016191 Publications
   Previous P50 Publications
Gregory L. Stahl
Principal Investigator

Laboratory Website
Visiting Professors (Photos)

Harvard Medical School - Brigham and Women's Hospital

Affiliate Faculty - 2005
Geraldine Canny, Ph.D., Director, Mucosal Immunity Laboratory, University Hospital of Lausanne, Switzerland
Nan Chiang, Ph.D., Instructor, Anesthesiology, Brigham and Women’s Hospital
Sean Colgan, Ph.D., Kern Professor of Medicine, and Director, Mucosal Inflammation Program, University of Colorado, Denver
Glenn Furuta, M.D., Assistant Professor of Medicine, Children’s Hospital, Boston
Simon Gelman, M.D., Ph.D., Vandam/Covino Distinguished Professor of Anaesthesia, Brigham and Women’s Hospital
Karsten Gronert, Ph.D., Assistant Professor, Pharmacology, New York Medical Center
Melanie Hart, Ph.D., Instructor, Anesthesiology, Brigham and Women's Hospital
Song Hong, Ph.D., Instructor, Department of Anesthesiology, Brigham and Women's Hospital
Bruce D. Levy, M.D., Department of Medicine, Brigham and Women’s Hospital
Pin-Lan Li, M.D., Ph.D., Associate Professor, Medical College of Wisconsin
Nancy Louis, M.D., Instructor in Anaesthesia, Neonatal Div., Newborn Medicine, Brigham and Woman’s Hospital
Birgitta Schmidt, M.D., Assistant Director Dermatopathology, Department of Pathology, Children's Hospital
Stan Shernan, M.D., Department of Anesthesiology, Brigham and Women’s Hospital
Mary Walsh, Ph.D., Instructor, Anesthesiology, Brigham and Women’s Hospital

Visiting International Faculty - 2005:
Makoto Arita, Ph.D., University of Tokyo, Japan (Host lab: C.N. Serhan)
Marc Busche, MD, Medizinische Hochschule, Dept of Trauma Surgery, Hannover, Germany (Host Lab: GL Stahl)
Eva Särndahl, Ph.D., Linköping University, Sweden (Host lab: C.N. Serhan)
Jan Schwab, M.D Ph.D., University of Tuebingen, Germany (Host lab: C.N. Serhan)
Cormac Taylor, Ph.D., University College Dublin, Ireland (Host lab: S.P. Colgan)

Previous Faculty


A Note from the Center's Director, Charles N. Serhan

Opportunities in Interdisciplinary and Translational Research

Our Center for Experimental Therapeutics and Reperfusion Injury offers many opportunities for training in topics that are of interest in internal medicine, surgery, pathology and their respective subspecialties (hematology, nephrology, etc.). This Center is a multidisciplinary research effort with a cluster of talented faculty members that have both unique scientific expertise and perspective focusing on defining key molecular events of importance in the biopathogenesis of reperfusion injury, a sequence of events that affects many diseases including asthma, cardiovascular diseases, pulmonary and renal disorders, as well as diseases with inflammatory components such as arthritis and oral medicine with clinical sequelae such as periodontal disease. In addition to these clinical endpoints, the underlying interactions between blood cells and vascular tissues evoke acute inflammatory responses that can be initiated within the host stress in surgery and persist in the perioperative arena.

The perioperative arena represents a wide, unmet clinical challenge and need for development of novel therapeutics that, if achieved, can shorten the duration of perioperative holding time and eventual hospital stay. In many respects, the cell biology and molecular mechanisms that are involved in acute reperfusion injury as observed in the surgical arena resemble the cellular and molecular events that take place in acute inflammation and host defense. Hence, detailed understanding of these molecular mechanisms and events can provide a wealth of new information that could have wide-ranging implications for the medical subspecialties and our appreciation of host defense as well as preventative medicine.

Scope of Research

The research programs within the Center take a multidisciplinary approach. The current tools of molecular medicine, namely biochemistry, cell and molecular biology, pharmacology, physiology and structural elucidation of small molecule natural products, all converge, with representatives from each discipline focused on elucidating key components in ischemia and reperfusion injury. This provides a unique opportunity for program development and a balanced training environment, as evidenced by the large number of trainees and the strong extramural support to this the Center.

Mission Statements & Goals

An interdisciplinary research team of experienced as well as new investigators is assembled within the Center with the following general mission statements:

"To identify novel targets and pathways critical in regulating neutrophil-mediated inflammation and establish the templates for physiologic small molecule-based interventions."

and

"To define the molecular mechanisms underlying reperfusion injury and identify novel therapeutic interventions that can prevent cell injury."


From these two broad mission statements we have created a platform for the interweaving of molecular definition and put a focus on structural elucidation, physiology and pharmacology as they intertwine in a modern appreciation and powerful use of molecular biology in evaluating the cell biology of inflammation and reperfusion injury in animal models such as transgenic and knockout mice and genetically engineered larger animal models including transgenic rabbits.

To accomplish our objectives, the Center environment and structure provides a platform that brings together a group of investigators and faculty members who have recognized expertise in the areas of biochemistry, pharmacology, physiology, physiological chemistry, cell biology, and molecular biology, all with a special interest in white blood cell function and their interactions with cells of the vessel wall as well as mucosal lining. Hence, one focal strength of the Center is its multidisciplinary approach to the well-appreciated problems associated with aberrant neutrophil activation that can occur during inflammation in a wide range of clinical scenarios as well as in ischemia-reperfusion injury.

The individual research report narratives of the Center.s faculty (see individual web sites) indicates that research in each principal investigator.s laboratory tests hypothesis-driven research based on recent discoveries in their laboratories that are funded by several extramural research sources:

National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of General Medical Sciences

American Heart Association
Arthritis Foundation
Fulbright Scholars program
Crohn.s and Colitis Foundation


A strategic research cluster: This coming together of uniquely qualified investigators in a strategic alliance to solve problems of fundamental importance in the biomedical sciences places the Center in a highly unique and strategic position to rapidly translate very basic research discoveries at the molecular and cellular level into shaping thoughts regarding the pathobiology of human disease and potential novel approaches and clinical treatments. On the other side of this equation, the opportunity for a cross dialogue with clinicians and clinician-scientists provides scientists working in this Center the ability to articulate well informed hypotheses in their experiments, aimed to elucidate clinical observations and phenomena to provide insight and a basis for informed intervention. This unique alliance between clinicians, clinician-scientists and basic scientists within each laboratory within the Center places this group of investigators in a unique position to achieve success in their individual research programs.

Brigham and Women's Hospital Location and Environment

The laboratories of our faculty members are located in the Thorn building, floors 7 and 13 of the Brigham and Women's Hospital. Our location provides an opportunity for daily interactions between individual laboratories and a framework for synergy with faculty members of the Center, their trainees, postdoctoral fellows and research associates as well as other investigators located within the Thorn Medical Research Building and the Harvard Medical Research Community.